Kimberly Noonan
Family · Charlotte, NCNPI 1720035397
Payments from drug & device makers
Across 166 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$517
- AbbVie$406
- AstraZeneca$339
- Takeda Pharmaceuticals U.S.A., Inc.$226
- Biohaven Pharmaceuticals, Inc.$194
- Lilly USA, LLC$190
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,953100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $517 |
| AbbVie(2 entities) | 30 | $406 |
| AstraZeneca | 16 | $339 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $226 |
| Biohaven Pharmaceuticals, Inc. | 12 | $194 |
| Lilly USA, LLC | 12 | $190 |
| Amarin Pharma, Inc. | 12 | $183 |
| Merck | 9 | $150 |
| Amgen(2 entities) | 8 | $132 |
| Boehringer Ingelheim | 6 | $105 |
| GSK | 6 | $103 |
| Sanofi | 1 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $80 |
| Daiichi Sankyo Inc. | 4 | $59 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Eisai Inc. | 2 | $31 |
| Johnson & Johnson | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Bayer | 1 | $18 |
| Novartis | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,955 in reported general payments places this provider in the 85th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 22 | $218 |
| Amlodipine Besylate | 22 | $192 |
Paid to pharmacies, not to this prescriber.
Other family in Charlotte
- Debra ScottCharlotte$129K
- Lasherri LeathersCharlotte$89K
- Catherine ShahCharlotte$72K
- Jason HardinCharlotte$37K
- Laura ListonCharlotte$33K
- Marie KristensenCharlotte$30K
- Hadley DebergCharlotte$16K
- Morgan HubeliCharlotte$15K
- Trisha WootenCharlotte$15K
- Samantha GriffinCharlotte$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.